{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:21:32Z","timestamp":1789042892425,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59194-3","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:13:42Z","timestamp":1781968422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["mRNA vaccine design targeting Merkel cell polyomavirus for immunotherapy of Merkel cell carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Akmal","family":"Zubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yaqoob","family":"Shahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Afghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"5866","key":"59194_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng, H. et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (5866), 1096\u20131100 (2008).","journal-title":"Science"},{"issue":"1732","key":"59194_CR2","doi-asserted-by":"publisher","first-page":"20160276","DOI":"10.1098\/rstb.2016.0276","volume":"372","author":"JA DeCaprio","year":"2017","unstructured":"DeCaprio, J. A. Merkel cell polyomavirus and Merkel cell carcinoma. Philos. Trans. R Soc. Lond. B Biol. Sci. 372 (1732), 20160276 (2017).","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"59194_CR3","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker, J. C. et al. Merkel cell carcinoma. Nat. Rev. Dis. Primers. 3, 17077 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"59194_CR4","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/cancers12071774","volume":"12","author":"V Pietropaolo","year":"2020","unstructured":"Pietropaolo, V., Prezioso, C. & Moens, U. Merkel cell polyomavirus and merkel cell carcinoma. Cancers (Basel). 12 (7), 1774 (2020).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"59194_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2017.10.028","volume":"78","author":"KG Paulson","year":"2018","unstructured":"Paulson, K. G. et al. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics. J. Am. Acad. Dermatol. 78 (3), 457\u2013463e2 (2018).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"59194_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","volume":"58","author":"M Heath","year":"2008","unstructured":"Heath, M. et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J. Am. Acad. Dermatol. 58 (3), 375\u2013381 (2008).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"59194_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","volume":"11","author":"Y Yang","year":"2015","unstructured":"Yang, Y. et al. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations. Hum. Vaccin Immunother. 11 (3), 795\u2013805 (2015).","journal-title":"Hum. Vaccin Immunother"},{"issue":"5","key":"59194_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian, S. L. et al. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat. Rev. Cancer. 16 (5), 275\u2013287 (2016).","journal-title":"Nat. Rev. Cancer"},{"issue":"42","key":"59194_CR9","doi-asserted-by":"publisher","first-page":"16272","DOI":"10.1073\/pnas.0806526105","volume":"105","author":"M Shuda","year":"2008","unstructured":"Shuda, M. et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl. Acad. Sci. U S A. 105 (42), 16272\u201316277 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"59194_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ijc.26076","volume":"130","author":"R Houben","year":"2012","unstructured":"Houben, R. et al. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int. J. Cancer. 130 (4), 847\u2013856 (2012).","journal-title":"Int. J. Cancer"},{"issue":"7","key":"59194_CR11","doi-asserted-by":"publisher","first-page":"e1002738","DOI":"10.1371\/journal.ppat.1002738","volume":"8","author":"U Neu","year":"2012","unstructured":"Neu, U. et al. Structures of Merkel cell polyomavirus VP1 complexes define a sialic acid binding site required for infection. PLoS Pathog. 8 (7), e1002738 (2012).","journal-title":"PLoS Pathog"},{"issue":"1","key":"59194_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13027-017-0122-0","volume":"12","author":"S Delbue","year":"2017","unstructured":"Delbue, S., Comar, M. & Ferrante, P. Review on the role of the human Polyomavirus JC in the development of tumors. Infect. agents cancer. 12 (1), 10 (2017).","journal-title":"Infect. agents cancer"},{"issue":"6","key":"59194_CR13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/ijc.24509","volume":"125","author":"YL Tolstov","year":"2009","unstructured":"Tolstov, Y. L. et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer. 125 (6), 1250\u20131256 (2009).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"59194_CR14","doi-asserted-by":"publisher","first-page":"e1000363","DOI":"10.1371\/journal.ppat.1000363","volume":"5","author":"JM Kean","year":"2009","unstructured":"Kean, J. M. et al. Seroepidemiology of human polyomaviruses. PLoS Pathog. 5 (3), e1000363 (2009).","journal-title":"PLoS Pathog"},{"issue":"1","key":"59194_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1586\/14760584.3.1.59","volume":"3","author":"AS De Groot","year":"2004","unstructured":"De Groot, A. S. & Rappuoli, R. Genome-derived vaccines. Expert Rev. Vaccines. 3 (1), 59\u201376 (2004).","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"59194_CR16","doi-asserted-by":"publisher","first-page":"120139","DOI":"10.1098\/rsob.120139","volume":"3","author":"A Patronov","year":"2013","unstructured":"Patronov, A. & Doytchinova, I. T-cell epitope vaccine design by immunoinformatics. Open. Biol. 3 (1), 120139 (2013).","journal-title":"Open. Biol."},{"issue":"2","key":"59194_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1039\/C5SC03892H","volume":"7","author":"M Skwarczynski","year":"2016","unstructured":"Skwarczynski, M. & Toth, I. Peptide-based synthetic vaccines. Chem. Sci. 7 (2), 842\u2013854 (2016).","journal-title":"Chem. Sci."},{"key":"59194_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","volume":"349","author":"N Nezafat","year":"2014","unstructured":"Nezafat, N. et al. A novel multi-epitope peptide vaccine against cancer: an in silico approach. J. Theor. Biol. 349, 121\u2013134 (2014).","journal-title":"J. Theor. Biol."},{"key":"59194_CR19","doi-asserted-by":"publisher","first-page":"105279","DOI":"10.1016\/j.ejps.2020.105279","volume":"147","author":"V Chauhan","year":"2020","unstructured":"Chauhan, V. & Singh, M. P. Immuno-informatics approach to design a multi-epitope vaccine to combat cytomegalovirus infection. Eur. J. Pharm. Sci. 147, 105279 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"59194_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N. et al. mRNA vaccines - a new era in vaccinology. Nat. Rev. Drug Discov. 17 (4), 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"10","key":"59194_CR21","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics\u2013developing a new class of drugs. Nat. Rev. Drug Discov. 13 (10), 759\u2013780 (2014).","journal-title":"Nat. Rev. Drug Discov"},{"key":"59194_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Advances in mRNA vaccines for infectious diseases. Front. Immunol. 10, 594 (2019).","journal-title":"Front. Immunol."},{"issue":"4","key":"59194_CR23","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette, A. & Rappuoli, R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33 (4), 530\u2013541 (2010).","journal-title":"Immunity"},{"issue":"3","key":"59194_CR24","doi-asserted-by":"publisher","first-page":"e0317382","DOI":"10.1371\/journal.pone.0317382","volume":"20","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the Asia. PLOS ONE. 20 (3), e0317382 (2025).","journal-title":"PLOS ONE"},{"issue":"D1","key":"59194_CR25","doi-asserted-by":"publisher","first-page":"D10","DOI":"10.1093\/nar\/gkaa892","volume":"49","author":"EW Sayers","year":"2021","unstructured":"Sayers, E. W. et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 49 (D1), D10\u2013D17 (2021).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"59194_CR26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8 (1), 4 (2007).","journal-title":"BMC Bioinform."},{"issue":"W1","key":"59194_CR27","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B. et al. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48 (W1), W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"59194_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/1471-2105-8-424","volume":"8","author":"MV Larsen","year":"2007","unstructured":"Larsen, M. V. et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinform. 8 (1), 424 (2007).","journal-title":"BMC Bioinform."},{"key":"59194_CR29","doi-asserted-by":"publisher","first-page":"102215","DOI":"10.1016\/j.coi.2022.102215","volume":"77","author":"JJ Baljon","year":"2022","unstructured":"Baljon, J. J. & Wilson, J. T. Bioinspired vaccines to enhance MHC class-I antigen cross-presentation. Curr. Opin. Immunol. 77, 102215 (2022).","journal-title":"Curr. Opin. Immunol."},{"issue":"D1","key":"59194_CR30","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2019","unstructured":"Vita, R. et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 47 (D1), D339\u2013D343 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"59194_CR31","first-page":"2680160","volume":"2017","author":"JL Sanchez-Trincado","year":"2017","unstructured":"Sanchez-Trincado, J. L., Gomez-Perosanz, M. & Reche, P. A. Fundamentals and methods for T-and B-cell epitope prediction. J. Immunol. Res. 2017 (1), 2680160 (2017).","journal-title":"J. Immunol. Res."},{"issue":"20","key":"59194_CR32","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.1073\/pnas.89.20.9612","volume":"89","author":"F Lejbkowicz","year":"1992","unstructured":"Lejbkowicz, F. et al. A fraction of the mRNA 5\u2019cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc. Natl. Acad. Sci. 89 (20), 9612\u20139616 (1992).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"59194_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-022-01007-w","volume":"7","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal. Transduct. Target. Ther. 7 (1), 166 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"59194_CR34","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.insi.2025.100046","volume":"1","author":"EK Oladipo","year":"2025","unstructured":"Oladipo, E. K. et al. Immunoinformatics-based strategies for mRNA vaccine development against Ilesha Virus. Silico Res. Biomed. 1, 100046 (2025).","journal-title":"Silico Res. Biomed."},{"key":"59194_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. 8, 4 (2007).","journal-title":"BMC Bioinform."},{"issue":"6","key":"59194_CR36","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I. et al. AllerTOP v. 2\u2014a server for in silico prediction of allergens. J. Mol. Model. 20 (6), 2278 (2014).","journal-title":"J. Mol. Model."},{"issue":"5","key":"59194_CR37","doi-asserted-by":"publisher","first-page":"bbac174","DOI":"10.1093\/bib\/bbac174","volume":"23","author":"N Sharma","year":"2022","unstructured":"Sharma, N. et al. ToxinPred2: an improved method for predicting toxicity of proteins. Brief. Bioinform. 23 (5), bbac174 (2022).","journal-title":"Brief. Bioinform"},{"key":"59194_CR38","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server. In The proteomics protocols handbook 571\u2013607 (Springer, 2005).","DOI":"10.1385\/1-59259-890-0:571"},{"issue":"19","key":"59194_CR39","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch, M. et al. Protein\u2013Sol: a web tool for predicting protein solubility from sequence. Bioinformatics 33 (19), 3098\u20133100 (2017).","journal-title":"Bioinformatics"},{"issue":"W1","key":"59194_CR40","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R. et al. iMODS: internal coordinates normal mode analysis server. Nucleic Acids Res. 42 (W1), W271\u2013W276 (2014).","journal-title":"Nucleic Acids Res."},{"issue":"18","key":"59194_CR41","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.3390\/molecules24183293","volume":"24","author":"JA Bauer","year":"2019","unstructured":"Bauer, J. A. & Pavlovi\u0107, J. Bauerov\u00e1-Hlinkov\u00e1, V. Normal mode analysis as a routine part of a structural investigation. Molecules 24 (18), 3293 (2019).","journal-title":"Molecules"},{"issue":"1","key":"59194_CR42","doi-asserted-by":"publisher","first-page":"15581","DOI":"10.1038\/s41598-026-46213-6","volume":"16","author":"A Zubair","year":"2026","unstructured":"Zubair, A. et al. Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses. Sci. Rep. 16 (1), 15581 (2026).","journal-title":"Sci. Rep."},{"issue":"1","key":"59194_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13062-026-00740-4","volume":"21","author":"S He","year":"2026","unstructured":"He, S. et al. Integrative bioinformatics approach to the mRNA vaccine development for the human papillomavirus using the capsid protein. Biol. Direct. 21 (1), 38 (2026).","journal-title":"Biol. Direct"},{"issue":"3","key":"59194_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s40203-025-00428-z","volume":"13","author":"IU Haq","year":"2025","unstructured":"Haq, I. U. et al. Using immunoinformatics and bioinformatics approach to design novel and effective rational in-silico vaccine against human Astrovirus targeting the capsid polyprotein VP90: a silent threat to global gastrointestinal tract. Silico Pharmacol. 13 (3), 139 (2025).","journal-title":"Silico Pharmacol."},{"issue":"5439","key":"59194_CR45","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1126\/science.286.5439.525","volume":"286","author":"D Yang","year":"1999","unstructured":"Yang, D. et al. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (5439), 525\u2013528 (1999).","journal-title":"Science"},{"issue":"2","key":"59194_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/jid.2012.319","volume":"133","author":"LK Ferris","year":"2013","unstructured":"Ferris, L. K. et al. Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant. J. Invest. Dermatol. 133 (2), 460\u2013468 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"59194_CR47","doi-asserted-by":"crossref","unstructured":"Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server. In The proteomics protocols handbook 571\u2013607. (2005).","DOI":"10.1385\/1-59259-890-0:571"},{"key":"59194_CR48","doi-asserted-by":"publisher","unstructured":"Latif, K. et al. Integrative immunoinformatics and molecular modeling approaches for the rational design and in silico validation of a multi-epitope vaccine candidate against human herpesvirusa 7. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05258-0 (2026).","DOI":"10.1007\/s00210-026-05258-0"},{"issue":"1","key":"59194_CR49","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1186\/s12879-025-12105-9","volume":"25","author":"A Kanwal","year":"2025","unstructured":"Kanwal, A. et al. Computational development of multi-epitope vaccine to induce adaptive immunity against multi-drug resistant Prevotella intermedia. BMC Infect. Dis. 25 (1), 1674 (2025).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"59194_CR50","doi-asserted-by":"publisher","first-page":"43984","DOI":"10.1038\/s41598-025-27720-4","volume":"15","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Molecular assessment of the HIV pol gene and use of computational vaccine design targeting Pakistani isolates. Sci. Rep. 15 (1), 43984 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"59194_CR51","doi-asserted-by":"publisher","first-page":"33690","DOI":"10.1038\/s41598-025-18828-8","volume":"15","author":"A Zubair","year":"2025","unstructured":"Zubair, A. et al. Integrative genomic and immunoinformatic approach for characterizing HIV-1 pol, vpr, and Nef genes and designing a multi-epitope vaccine. Sci. Rep. 15 (1), 33690 (2025).","journal-title":"Sci. Rep."},{"issue":"5","key":"59194_CR52","doi-asserted-by":"publisher","first-page":"e16148","DOI":"10.1016\/j.heliyon.2023.e16148","volume":"9","author":"SN Nasir","year":"2023","unstructured":"Nasir, S. N. et al. Structural vaccinology-based design of multi-epitopes vaccine against Streptococcus gordonii and validation using molecular modeling and immune simulation approaches. Heliyon 9 (5), e16148 (2023).","journal-title":"Heliyon"},{"issue":"47","key":"59194_CR53","doi-asserted-by":"publisher","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","volume":"6","author":"SA Sami","year":"2021","unstructured":"Sami, S. A. et al. Designing of a multi-epitope vaccine against the structural proteins of marburg virus exploiting the immunoinformatics approach. ACS Omega. 6 (47), 32043\u201332071 (2021).","journal-title":"ACS Omega"},{"issue":"3","key":"59194_CR54","doi-asserted-by":"publisher","first-page":"500463","DOI":"10.1016\/j.vacune.2025.500463","volume":"26","author":"M Rahiyab","year":"2025","unstructured":"Rahiyab, M. et al. Design of a new multi-epitope subunit vaccine to combat the EIA virus, targeting Pol, Gag, and Env proteins: In silico technique. Vacunas (English Edition). 26 (3), 500463 (2025).","journal-title":"Vacunas (English Edition)"},{"issue":"12","key":"59194_CR55","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1021\/acs.jcim.3c00419","volume":"63","author":"M Bz\u00f3wka","year":"2023","unstructured":"Bz\u00f3wka, M., Bagrowska, W. & G\u00f3ra, A. Recent advances in studying toll-like receptors with the use of computational methods. J. Chem. Inf. Model. 63 (12), 3669\u20133687 (2023).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"59194_CR56","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41541-021-00391-8","volume":"6","author":"R Sartorius","year":"2021","unstructured":"Sartorius, R. et al. Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines. npj Vaccines. 6 (1), 127 (2021).","journal-title":"npj Vaccines"},{"key":"59194_CR57","doi-asserted-by":"publisher","unstructured":"Ullah, N. et al. In-silico design of a novel multi-epitope vaccine against Chapare virus using integrated immunoinformatics and bioinformatics approaches. Med. Omics. https:\/\/doi.org\/10.1016\/j.meomic.2026.100059 (2026).","DOI":"10.1016\/j.meomic.2026.100059"},{"issue":"1","key":"59194_CR58","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1038\/s41598-026-35678-0","volume":"16","author":"D Ishwar","year":"2026","unstructured":"Ishwar, D. et al. In silico design of a multi-epitope vaccine targeting DENV-1 and DENV-3. Sci. Rep. 16 (1), 5308 (2026).","journal-title":"Sci. Rep."},{"key":"59194_CR59","doi-asserted-by":"publisher","first-page":"1221008","DOI":"10.3389\/fimmu.2023.1221008","volume":"14","author":"T Ung","year":"2023","unstructured":"Ung, T. et al. Cell-targeted vaccines: implications for adaptive immunity. Front. Immunol. 14, 1221008 (2023).","journal-title":"Front. Immunol."},{"issue":"4","key":"59194_CR60","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.immuni.2010.10.007","volume":"33","author":"K Palucka","year":"2010","unstructured":"Palucka, K., Banchereau, J. & Mellman, I. Designing Vaccines based on biology of human dendritic cell subsets. Immunity 33 (4), 464\u2013478 (2010).","journal-title":"Immunity"},{"issue":"1","key":"59194_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s43141-022-00391-8","volume":"20","author":"SI Islam","year":"2022","unstructured":"Islam, S. I., Mou, M. J. & Sanjida, S. Application of reverse vaccinology to design a multi-epitope subunit vaccine against a new strain of Aeromonas veronii. J. Genet. Eng. Biotechnol. 20 (1), 118 (2022).","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"59194_CR62","first-page":"102498","volume":"45","author":"N Rahimi-Farsi","year":"2026","unstructured":"Rahimi-Farsi, N. et al. Immunoinformatic-driven design of a multi-epitope vaccine against Helicobacter pylori. Biochem. Biophys. Rep. 45, 102498 (2026).","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"59194_CR63","doi-asserted-by":"publisher","first-page":"9562","DOI":"10.1038\/s41598-025-92956-z","volume":"15","author":"V Deepthi","year":"2025","unstructured":"Deepthi, V. et al. Computationally designed multi-epitope vaccine construct targeting the SARS-CoV-2 spike protein elicits robust immune responses in silico. Sci. Rep. 15 (1), 9562 (2025).","journal-title":"Sci. Rep."},{"key":"59194_CR64","doi-asserted-by":"publisher","first-page":"15581","DOI":"10.1038\/s41598-026-46213-6","volume":"16","author":"A Zubair","year":"2026","unstructured":"Zubair, A. et al. Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses. Sci. Rep. 16, 15581 (2026).","journal-title":"Sci. Rep."},{"issue":"3","key":"59194_CR65","doi-asserted-by":"publisher","first-page":"500427","DOI":"10.1016\/j.vacun.2025.500427","volume":"26","author":"Najeebullah","year":"2025","unstructured":"Najeebullah et al. Rational in-silico design of a multi-epitope vaccine against human Rhinovirus an immune simulation and molecular dynamics simulation approach. Vacunas 26 (3), 500427 (2025).","journal-title":"Vacunas"},{"issue":"1","key":"59194_CR66","doi-asserted-by":"publisher","first-page":"bbaf055","DOI":"10.1093\/bib\/bbaf055","volume":"26","author":"Y Wei","year":"2024","unstructured":"Wei, Y. et al. Advances of computational methods enhance the development of multi-epitope vaccines. Brief. Bioinform. 26 (1), bbaf055 (2024).","journal-title":"Brief. Bioinform"},{"issue":"9","key":"59194_CR67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/ph18091258","volume":"18","author":"KS Allemailem","year":"2025","unstructured":"Allemailem, K. S. In silico development of a chimeric multi-epitope vaccine targeting Helcococcus kunzii: Coupling subtractive proteomics and reverse vaccinology for vaccine target discovery. Pharmaceuticals 18 (9), 1258 (2025).","journal-title":"Pharmaceuticals"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59194-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:02:48Z","timestamp":1789041768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59194"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59194-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is complete in silico work and doesn\u2019t require ethical approval.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research does not include any human or animal subjects.","order":3,"name":"Ethics","label":"Human or animal rights","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28320"}}